Abbott Laboratories (XSWX:ABT) Inventories, Finished Goods: CHF3,365 Mil (As of Mar. 2026)


XSWX:ABT Abbott Laboratories XSWX:ABT
80 GF Score
Price CHF74.50
GF Value CHF105.05
View Full Analysis

What is Abbott Laboratories Inventories, Finished Goods?

Abbott Laboratories XSWX:ABT 80 Inventories, Finished Goods is CHF3,365 Mil as of Mar. 2026. GuruFocus rates XSWX:ABT with a GF Score™ of 80/100 and a GF Value™ of CHF105.05.

Abbott Laboratories's quarterly finished goods declined from Sep. 2025 (CHF3,288 Mil) to Dec. 2025 (CHF3,168 Mil) but then increased from Dec. 2025 (CHF3,168 Mil) to Mar. 2026 (CHF3,365 Mil).

Abbott Laboratories's annual finished goods declined from Dec. 2023 (CHF3,413 Mil) to Dec. 2024 (CHF3,299 Mil) and declined from Dec. 2024 (CHF3,299 Mil) to Dec. 2025 (CHF3,168 Mil).

Abbott Laboratories Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Abbott Laboratories's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories Inventories, Finished Goods Chart

Abbott Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,837.60 3,544.74 3,412.50 3,298.92 3,168.47

Abbott Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,590.07 3,512.21 3,287.89 3,168.47 3,364.92
XSWX:ABT
80GF Score
Abbott Laboratories XSWX:ABT
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbott Laboratories Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of CHF3,365 Mil mean?
Abbott Laboratories (XSWX:ABT) has a Inventories, Finished Goods of CHF3,365 Mil as of Mar. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on Abbott Laboratories and its competitors.
Is Abbott Laboratories' Inventories, Finished Goods too high?
Abbott Laboratories' current Inventories, Finished Goods is CHF3,365 Mil. Overall, Abbott Laboratories has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' Inventories, Finished Goods compare to SYK and MDT?
Abbott Laboratories' Inventories, Finished Goods of CHF3,365 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Medical Devices & Instruments company?
A good Inventories, Finished Goods depends on the Medical Devices & Instruments industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Abbott Laboratories and its competitors. Abbott Laboratories's current Inventories, Finished Goods is CHF3,365 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Abbott Laboratories (XSWX:ABT) has a current Inventories, Finished Goods of CHF3,365 Mil. The stock's GF Value™ is CHF105.05, compared to a current price of CHF74.50 — trading 29.1% below its estimated fair value. The current Inventories, Finished Goods is CHF3,365 Mil. Abbott Laboratories' overall GF Score™ is 80/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Abbott Laboratories (XSWX:ABT), the current Inventories, Finished Goods is CHF3,365 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbott Laboratories (XSWX:ABT) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued. The current stock price of CHF74.50 is trading 29.1% below its estimated GF Value™ of CHF105.05.

Key valuation signals for XSWX:ABT:

  • Inventories, Finished Goods: CHF3,365 Mil
  • GF Value™: CHF105.05 vs. price of CHF74.50 (29.1% below fair value)
  • GF Score™: 80/100

No single metric tells the full story. See the XSWX:ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Abbott Laboratories Business Description

Address 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
80GF Score

Get the complete analysis for XSWX:ABT

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF74.50
Price
CHF105.05
GF Value